Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrius Baskys

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|December 18, 2010
Regulating genetic tests: who owns the data?Andrius Baskys
Journal of Neural Transmission (Vienna, Austria : 1996)|June 21, 2018
Application of pharmacogenetics in clinical practice: problems and solutionsAndrius Baskys
The Journal of Clinical Psychiatry|July 22, 2004
Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptomsAndrius Baskys
Journal of Alzheimer'S Disease : JAD|July 16, 2014
Integration of genomic information in development of pharmacological vascular dementia prevention and treatment strategiesAndrius Baskys
American Journal of Alzheimer'S Disease and Other Dementias|November 9, 2005
Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled studyJennifer Koontz, Andrius Baskys
Journal of the Neurological Sciences|March 12, 2005
Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategiesAndrius Baskys, Morten Blaabjerg
Experimental Gerontology|July 17, 2012
Pharmacological prevention and treatment of vascular dementia: approaches and perspectivesAndrius Baskys, Jin-xiang Cheng
Clinical Interventions in Aging|November 30, 2007
Vascular dementia: pharmacological treatment approaches and perspectivesAndrius Baskys, Anthony C Hou
Annals of the New York Academy of Sciences|September 24, 2005
Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?Andrius Baskys, Liwei Fang, Ildar Bayazitov
Experimental Neurology|October 14, 2003
Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currentsMorten Blaabjerg, Liwei Fang, Jens Zimmer, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|December 18, 2010
Regulating genetic tests: who owns the data?Andrius Baskys
Journal of Neural Transmission (Vienna, Austria : 1996)|June 21, 2018
Application of pharmacogenetics in clinical practice: problems and solutionsAndrius Baskys
The Journal of Clinical Psychiatry|July 22, 2004
Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptomsAndrius Baskys
Journal of Alzheimer'S Disease : JAD|July 16, 2014
Integration of genomic information in development of pharmacological vascular dementia prevention and treatment strategiesAndrius Baskys
American Journal of Alzheimer'S Disease and Other Dementias|November 9, 2005
Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled studyJennifer Koontz, Andrius Baskys
Journal of the Neurological Sciences|March 12, 2005
Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategiesAndrius Baskys, Morten Blaabjerg
Experimental Gerontology|July 17, 2012
Pharmacological prevention and treatment of vascular dementia: approaches and perspectivesAndrius Baskys, Jin-xiang Cheng
Clinical Interventions in Aging|November 30, 2007
Vascular dementia: pharmacological treatment approaches and perspectivesAndrius Baskys, Anthony C Hou
Annals of the New York Academy of Sciences|September 24, 2005
Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?Andrius Baskys, Liwei Fang, Ildar Bayazitov
Experimental Neurology|October 14, 2003
Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currentsMorten Blaabjerg, Liwei Fang, Jens Zimmer, et al.
Pageof 4